Mamiko Yamada

Dr. Mamiko Yamada

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2022 in European Journal of Medical Genetics
Verified
Journal Article
Open access
MYMamiko Yamada
Mamiko Yamada
HOHironobu Okuno
Hironobu Okuno
NONobuhiko Okamoto
Nobuhiko Okamoto
HSHisato Suzuki
Hisato Suzuki
FMFuyuki Miya
Fuyuki Miya
KKKenjiro Kosaki
Kenjiro Kosaki
The CpG island flanking the promoter region of SNRPN on chromosome 15q11.2 contains CpG sites that are completely methylated in the maternally derived allele and unmethylated in the paternally derived allele. Both unmethylated and methylated alleles are observed in normal individuals. Only the methylated allele is observed in patients with Prader-Willi syndrome, whereas only the unmethylated allele is observed in those with Angelman syndrome. Hence, detection of aberrant methylation at the differentially methylated region is fundamental to the molecular diagnosis of Prader-Willi syndrome and Angelman syndromes. Traditionally, bisulfite treatment and methylation-sensitive restriction enzyme treatment or methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) have been used. We here developed a long-read sequencing assay that can distinguish methylated and unmethylated CpG sites at 15q11.2 by the difference in current intensity generated from nanopore reads. We successfully diagnosed 4 Prader-Willi syndrome patients and 3 Angelman syndrome patients by targeting differentially methylated regions. Concurrent copy number analysis, homozygosity analysis, and structural variant analysis also allowed us to precisely delineate the underlying pathogenic mechanisms, including gross deletion, uniparental heterodisomy, uniparental isodisomy, or imprinting defect. Furthermore, we showed allele-specific methylation in imprinting-related differentially methylated regions on chromosomes 6, 7, 11, 14, and 20 in a normal individual together with 4 Prader-Willi patients and 3 Angelman syndrome patients. Hence, presently reported method is likely to be applicable to the diagnosis of imprinting disorders other than Prader-Willi syndrome and Angelman syndrome as well.

31 December 2020 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
HSHisato Suzuki
Hisato Suzuki
MIMie Inaba
Mie Inaba
MYMamiko Yamada
Mamiko Yamada
TUTomoko Uehara
Tomoko Uehara
TTToshiki Takenouchi
Toshiki Takenouchi
MDMotomichi Doi
Motomichi Doi

25 June 2023 in European Journal of Medical Genetics
Verified
Journal Article
Closed access
MYMamiko Yamada
Mamiko Yamada
YNYohei Nitta
Yohei Nitta
TUTomoko Uehara
Tomoko Uehara
HSHisato Suzuki
Hisato Suzuki
FMFuyuki Miya
Fuyuki Miya
ASAtsushi Sugie
Atsushi Sugie

1 June 2020 in The Journal of Pediatrics
Verified
Journal Article
Closed access
TUTomoko Uehara
Tomoko Uehara
MYMamiko Yamada
Mamiko Yamada
SUShuichiro Umetsu
Shuichiro Umetsu
HNHiroshi Nittono
Hiroshi Nittono
HSHisato Suzuki
Hisato Suzuki
KKKenjiro Kosaki
Kenjiro Kosaki

28 October 2020 in Congenital Anomalies
Verified
Journal Article
Closed access
PDF file
MYMamiko Yamada
Mamiko Yamada
HSHisato Suzuki
Hisato Suzuki
AWAkiko Watanabe
Akiko Watanabe
TUTomoko Uehara
Tomoko Uehara
TTToshiki Takenouchi
Toshiki Takenouchi
KKKenjiro Kosaki
Kenjiro Kosaki

15 May 2020 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
MYMamiko Yamada
Mamiko Yamada
TUTomoko Uehara
Tomoko Uehara
HSHisato Suzuki
Hisato Suzuki
TTToshiki Takenouchi
Toshiki Takenouchi
AIAyano Inui
Ayano Inui
KKKenjiro Kosaki
Kenjiro Kosaki